Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Sat Dec 16 18:19:58 UTC 2023
by
admin
on
Sat Dec 16 18:19:58 UTC 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | ALLOGENIC HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Material Type | CELL |
| Fraction Name | MONOCYTES |
| Record UNII |
PY29292DVJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
864821
Created by
admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
788320
Created by
admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
796120
Created by
admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10532
Created by
admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
|
PRIMARY | |||
|
PY29292DVJ
Created by
admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
|
PRIMARY | |||
|
C99902
Created by
admin on Sat Dec 16 18:19:58 UTC 2023 , Edited by admin on Sat Dec 16 18:19:58 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Injection of these cells in the patient's tumor generates an inflammatory response which in turns leads to tumor-specific activation of the patient's cytotoxic T cells
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CULTURE | RESIQUIMOD | V3DMU7PVXF |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
|
|||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
PW3DO1LF7X
HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
(not present in database)
|
|
||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
|
|||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
|
|||
